Chatterjee, et al., Cancer Immunol. Immunother. 38: 75-82 (1994). |
Gura, et al., Science 278: 1041-1042 (1997). |
Mendelsohn, J., Clin. Canc. Res. 3: 2703-2707, (1997). |
Newell, M.K., et al., “Ligation of major histocompayibility complex class II molecules mediates apoptocic cell death in resting B lymphocytes”Proc. Natl. Acad. Sci. USA 90: 10459-10463 (1993). |
Schlom, J., Molecular Goundations of Oncology pp. 98 (1991). |
Truman, J-P., et al., “Lymphocyte programmed cell death is mediated via HLA class II DR” International Immunology 6 (6) :887-896 (1994). |
Vidovic, D., et al., “Down-regulation of class II major histocompatiblity complex molecules on antigen-presenting cells by antibody fragments” Eur. J. Immunol. 25:3349-3355 (1995). |
Vidoviÿ, D., and Toral, J.I., “Selective apoptosis of neoplastic cells by the HLA-DR-specific monoclonal antibody” Cancer Letters 128 (2):127-135 (1988). |